Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes Federal Judge’s Refusal to Dismiss Certain Claims in Pradaxa Lawsuit
The Firm is investigating Pradaxa lawsuits on behalf of individuals treated with the blood thinner who allegedly suffered life-threatening episodes of internal bleeding due to its use.
New York, New York (PRWEB) January 16, 2014
Bernstein Liebhard LLP continues to monitor developments involving the thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/ ) filed on behalf of individuals who allegedly suffered life-threatening episodes of internal bleeding due to their use of the blood thinner. According to court documents filed in the U.S District Court, Southern District of Illinois, the judge overseeing the federal Pradaxa litigation has refused to dismiss claims in one lawsuit based on alleged violations of the Food, Drug and Cosmetic Act (FDCA). In doing so, U.S. District Judge David Herndon noted that the five plaintiffs named in the Pradaxa lawsuit had not filed their lawsuit directly under the Act. Rather, the alleged FDCA violations referred to in their claim appeared to be offered in order to establish the duty Boehringer Ingelheim allegedly failed to meet in relation to the state law claims put forth in the complaint. (Butner, et al. v. Boehringer Ingelheim Pharmaceuticals Inc., et al., No. 3:12-60092)
“Our Firm is investigating a number of Pradaxa lawsuits on behalf of individuals who experienced life-threatening episodes of internal bleeding, allegedly due to their use of this blood thinner. Many of their claims echo the allegations contained in this complaint,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa lawsuit evaluations to individuals who were allegedly harmed by this medication.
Pradaxa Bleeding Allegations
This Pradaxa lawsuit is just one of at least 2,086 currently pending in the Southern District of Illinois, all of which allege use of the blood thinner caused patients to experience dangerous and sometimes fatal episodes of internal hemorrhaging, including cerebral and gastrointestinal bleeding, The lawsuits further allege that Boehringer Ingelheim failed to provide patients and doctors with adequate warnings about these risks, including the fact that there currently exists no readily-available antidote to stop Pradaxa bleeding. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
According to a report issued by the Institute for Safe Medicine Practices in October, Pradaxa was associated with more adverse events in 2012 than any other drug monitored by the U.S. Food & Drug Administration (FDA). That year the FDA received more than 3,200 reports involving Pradaxa, including over 580 that had fatal outcomes. By contrast, warfarin, a blood thinner that’s been on the market for decades, was the named in only 861 incident reports, including 56 deaths.*
The FDA recently announced that it would conduct a large-scale study of Pradaxa bleeding rates in order to compare “selected safety outcomes in adults with atrial fibrillation who are new users of dabigatran or warfarin.”
Alleged victims of Pradaxa bleeding may be entitled to compensation for medical bills, lost wages, pain and suffering, and other injury-related damages. To learn more about filing a Pradaxa lawsuit, please visit Bernstein Liebhard LLP’s website. For a free case review, please call 800-511-5092.
*ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP, October 17, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
For the original version on PRWeb visit: http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb11496772.htm